Share on StockTwits

Shares of AstraZeneca plc (NYSE:AZN) have been given an average rating of “Hold” by the twenty-two ratings firms that are currently covering the stock, Stock Ratings News reports. Four analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have issued a buy rating on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $57.00.

A number of analysts have recently weighed in on AZN shares. Analysts at Panmure Gordon reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Friday. Separately, analysts at Deutsche Bank reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Friday. Finally, analysts at Beaufort Securities reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Friday.

AstraZeneca plc (NYSE:AZN) opened at 73.89 on Friday. AstraZeneca plc has a 52 week low of $48.53 and a 52 week high of $82.68. The stock has a 50-day moving average of $72.72 and a 200-day moving average of $70.88. The company has a market cap of $93.323 billion and a P/E ratio of 45.57.

AstraZeneca plc (NYSE:AZN) last announced its earnings results on Thursday, July 31st. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.21. The company had revenue of $6.45 billion for the quarter, compared to the consensus estimate of $6.24 billion. During the same quarter last year, the company posted $1.20 earnings per share. AstraZeneca plc’s revenue was up 3.6% compared to the same quarter last year. Analysts expect that AstraZeneca plc will post $4.40 EPS for the current fiscal year.

The company also recently declared a semiannual dividend, which is scheduled for Monday, September 15th. Stockholders of record on Friday, August 15th will be given a dividend of $0.90 per share. This represents a yield of 2.48%. The ex-dividend date of this dividend is Wednesday, August 13th.

AstraZeneca PLC (NYSE:AZN) is a global biopharmaceutical company.

Receive News & Ratings for AstraZeneca plc (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca plc (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.